Skip to main content

Table 1 The clinical information of PCOS and control groups

From: MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4

Clinical index PCOS
(n = 50)
Control
(n = 50)
P
Age 30.98 ± 3.82 30.76 ± 3.12 0.753
E2 (pg/mL) 41.34 ± 12.05 37.65 ± 11.32 0.118
BMI (Kg/m2) 24.48 ± 2.62 22.63 ± 2.48 < 0.001
LH (mIU/mL) 9.35 ± 1.77 7.67 ± 1.80 < 0.001
FSH (mIU/mL) 8.22 ± 1.10 7.79 ± 1.12 0.051
PRL (mIU/L) 270.3 ± 132.5 227.9 ± 116.6 0.091
T (mIU/mL) 1.19 ± 0.53 0.522 ± 0.18 < 0.001
Glu (nmol/mL) 6.33 ± 2.00 5.31 ± 1.89 < 0.05
INS (μU/mL) 21.19 ± 3.79 13.25 ± 5.46 < 0.001
  1. E2 Estradiol, BMI Body Mass Index, LH Luteinizing hormone, FSH Follicule-stimulating hormone, PRL Prolactin, T Testostrone, Glu Glucose, INS Insulin